CD4 and neoplasm: Similarly, a lower concentration of Tregs with nuclear FoxP3 was found in the tumor of treated patients compared to controls whereas no differences were detected in the naïve (CD4+Foxp3−cells) or poorly activated [CD4+cells with cytoplasmic Foxp3 (55, 56)] CD4+T cells (Figure 5C).